Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Nov 28, 2018; 24(44): 5034-5045
Published online Nov 28, 2018. doi: 10.3748/wjg.v24.i44.5034
Figure 2
Figure 2 Area under the curve and 95% confidence interval at different time endpoints for risk score in derivation and validation cohorts. Data are presented as area under the curve (95% confidence interval). A: Discrimination of risk score 1 and risk score 2 for predicting 3-year chronic pancreatitis incidence in derivation cohort. B: Discrimination of risk score 1 and risk score 2 for predicting 5-year chronic pancreatitis incidence in derivation cohort. C: Discrimination of risk score 1 and risk score 2 for predicting overall chronic pancreatitis incidence in derivation cohort. D: Discrimination of risk score 1 and risk score 2 for predicting 3-year chronic pancreatitis incidence in validation cohort. E: Discrimination of risk score 1 and risk score 2 for predicting 5-year chronic pancreatitis incidence in validation cohort. F: Discrimination of risk score 1 and risk score 2 for predicting overall chronic pancreatitis incidence in validation cohort. AUC: Area under the curve; ROC: Receiver operating characteristic.